Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis.
about
Proteomic detection of cancer in asbestosis patients using SELDI-TOF discovered serum protein biomarkersMolecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.Associations of P16INK4a promoter hypermethylation with squamous intra-epithelial lesion, cervical cancer and their clinicopathological features: a meta-analysisEpigenetics and human disease: translating basic biology into clinical applicationsCigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: a longitudinal studyAn upward trend in DNA p16ink4a methylation pattern and high risk HPV infection according to the severity of the cervical lesionSmoking initiation is followed by the early acquisition of epigenetic change in cervical epithelium: a longitudinal study.Smoking and cervical cancer.Biomarkers of cervical dysplasia and carcinomaCigarette smoke induces promoter methylation of single-stranded DNA-binding protein 2 in human esophageal squamous cell carcinoma.p16(INK4a) and p15(INK4b) gene promoter methylation in cervical cancer patients.Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers.Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science.The association between methylated CDKN2A and cervical carcinogenesis, and its diagnostic value in cervical cancer: a meta-analysis.HPV infection and p16 promoter methylation as predictors of ASC-US/LSIL progression.Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.Recent advances in cancer outcomes in HIV-positive smokers.Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania.
P2860
Q23910532-0C11059E-14E9-4CCF-94E5-D4B9A862330EQ27824854-7767A75D-57E9-491A-909D-DB379A833FECQ28078542-671F79CC-CD98-4136-8710-2F1DC91560C4Q28768502-7A9C99E9-5AFD-4454-B9D7-8FB552C2BB4EQ33598568-B2E0F86D-778F-4D54-8C4B-937D703DC0CAQ33926462-F91A3AA9-C3D5-4A06-9290-21E74E235C21Q35006883-A2CDC61F-5793-4321-9A71-FA420739B95CQ35116969-573D8B41-9531-47AB-8277-546BEF50E89EQ35495173-0800249F-941B-498C-BE39-AC6FDC5E411CQ35506905-B5AACA22-835B-4556-8516-69BA41A74875Q36084349-129E7031-52E2-49E5-8B49-7536286611B8Q36982644-33F41880-C282-45FE-8B38-1DB5224089B7Q37151661-E697FE0A-AAEE-4D98-851E-FBB14C309B95Q37170521-A7A6C472-22BF-4BA0-90EB-2F569DE37D26Q37197245-EFAF78BE-A504-4E8B-BFEE-52376A85CF62Q40578877-A920FC8F-C02B-4C94-B456-E52F7830BFA3Q45838374-4E0DB523-3C8E-4494-8C0D-C88B93C4B279Q55266710-92B29901-31AE-4053-80AC-695B28D293C9Q55502790-192B124D-E1FE-42AA-9AEA-BB6FA7AFF96F
P2860
Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Aberrant p16 methylation is a ...... squamous cell carcinogenesis.
@ast
Aberrant p16 methylation is a ...... squamous cell carcinogenesis.
@en
type
label
Aberrant p16 methylation is a ...... squamous cell carcinogenesis.
@ast
Aberrant p16 methylation is a ...... squamous cell carcinogenesis.
@en
altLabel
Aberrant p16 methylation is a ...... l squamous cell carcinogenesis
@en
prefLabel
Aberrant p16 methylation is a ...... squamous cell carcinogenesis.
@ast
Aberrant p16 methylation is a ...... squamous cell carcinogenesis.
@en
P2093
P1476
Aberrant p16 methylation is a ...... squamous cell carcinogenesis.
@en
P2093
Aleena Kurien
David S Miller
Jayanthi S Lea
John D Minna
John O Schorge
Robert Coleman
P304
P356
10.1016/J.AJOG.2003.09.036
P407
P577
2004-03-01T00:00:00Z